137 related articles for article (PubMed ID: 24400982)
1. Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system.
Gong W; Liu Y; Mei DY; Yang M; Mei XG
Drug Dev Ind Pharm; 2015 Mar; 41(3):464-9. PubMed ID: 24400982
[TBL] [Abstract][Full Text] [Related]
2. Preparation and
Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
[TBL] [Abstract][Full Text] [Related]
3. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant.
Zhang X; Wang M; Li P; Wang A; Liang R; Gai Y; Liu W; Li Y; Sun K
Pharm Dev Technol; 2016 Dec; 21(8):1006-1014. PubMed ID: 26446857
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro/in vivo evaluation of vinpocetine elementary osmotic pump system.
Ning M; Zhou Y; Chen G; Mei X
Adv Pharmacol Sci; 2011; 2011():385469. PubMed ID: 21577257
[TBL] [Abstract][Full Text] [Related]
5. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs.
Shokri J; Ahmadi P; Rashidi P; Shahsavari M; Rajabi-Siahboomi A; Nokhodchi A
Eur J Pharm Biopharm; 2008 Feb; 68(2):289-97. PubMed ID: 17616378
[TBL] [Abstract][Full Text] [Related]
6. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation.
Gong W; Ma R; Mei D; Jing P; Dong X; Li B; Yang Y; Du L; Mei XG; Hu FQ
Drug Deliv; 2014 Feb; 21(1):1-7. PubMed ID: 24102136
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
Yanfei M; Guoguang C; Lili R; Pingkai O
Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
[TBL] [Abstract][Full Text] [Related]
8. A novel solubility-modulated granules through porosity osmotic pump for controlled carvedilol delivery.
Song QL; Li P; Li YM
Pharm Dev Technol; 2012; 17(6):666-76. PubMed ID: 21486184
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.
Lin W; Li Y; Shi Q; Liao X; Zeng Y; Tian W; Xie X; Liu H
PLoS One; 2022; 17(2):e0264457. PubMed ID: 35213658
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
[TBL] [Abstract][Full Text] [Related]
12. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W
Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493
[TBL] [Abstract][Full Text] [Related]
13. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
Pan H; Jing H; Yang X; Pan W; Chen T
Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets.
Ouyang D; Nie S; Li W; Guo H; Liu H; Pan W
J Pharm Pharmacol; 2005 Jul; 57(7):817-20. PubMed ID: 15969939
[TBL] [Abstract][Full Text] [Related]
15. Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology.
Zhao S; Yu F; Liu N; Di Z; Yan K; Liu Y; Li Y; Zhang H; Yang Y; Yang Z; Li Z; Mei X
Drug Dev Ind Pharm; 2016 Nov; 42(11):1723-31. PubMed ID: 27074758
[TBL] [Abstract][Full Text] [Related]
16. Comparative fasting bioavailability of dispersible and conventional tablets of risperidone: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy male Chinese volunteers.
Huang M; Shen-Tu J; Hu X; Chen J; Liu J; Wu L
Clin Ther; 2012 Jun; 34(6):1432-9. PubMed ID: 22595151
[TBL] [Abstract][Full Text] [Related]
17. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
Yanfei M; Guoguang C; Lili R; Pingkai O
Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
[TBL] [Abstract][Full Text] [Related]
19. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.
Liu L; Wang X
Eur J Pharm Biopharm; 2008 Feb; 68(2):298-302. PubMed ID: 17560099
[TBL] [Abstract][Full Text] [Related]
20. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
Patel KN; Mehta TA
PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
